AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Section V: Biomedical Sciences.

Georgia Journal of Science

| March 22, 2009 | COPYRIGHT 2009 Georgia Academy of Science. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2:00 PHYTOSTEROL SUPPLEMENTATION **, Lucky Nwankwo (1), Kereen

Gordon (2), Victoria Miles (2), Godwin Ifere (2), Qing He (3), Eno Ekong (3), Francis Eko (3), Joseph Igietseme (4) and Godwin Ananaba (1/2), (1) Center for Cancer Research & Therapeutic Development, (2) Clark Atlanta University, (3) Morehouse School of Medicine and (4) Centers for Disease Control and Prevention, Atlanta, GA. Interleukin-10 (IL-10) cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of The cytokines, MHC class II antigens, and co-stimulatory molecules on macrophages. IL-10 is an anti-inflammatory cytokine that depends on the JAK-STAT ...

Related articles from newspapers, magazines, journals, and more
CD4+ T cells kill Id+ B-lymphoma cells.
Newspaper article from: Drug Week December 31, 2004 700+ words
...vitro but is redundant in vivo. "B-lymphoma cells express a highly tumor-specific antigen...Previous work has demonstrated that B-lymphoma cells spontaneously process their endogenous...T cells protect mice against B-lymphoma cells in the absence of anti-idiotypic...
Scientists Identify Radiation-Sensitivity Gene in Leukemia and Lymphoma Cells
Press release article from: PR Newswire August 23, 1996 700+ words
...discovering how radiation kills leukemia/lymphoma cells, and how cancer cells resist radiation...replacing specific genes in leukemia and lymphoma cells, the researchers identified a gene...radiation resistance of leukemia and lymphoma cells, we can quickly determine how best...
Anti-CD30-scFv-Fc-IL-2 fusion induces resting NK cells to lyse lymphoma cells.
Newspaper article from: Biotech Week July 28, 2004 700+ words
...fusion induces resting NK cells to lyse lymphoma cells. "The pathogenesis of Hodgkin's...After binding to CD30+ Hodgkin lymphoma cells," Heuser continued, "HRS3-scFv...cells, but not T cells, to lyse the lymphoma cells with high efficiency." The authors...
HHV-8 vFLIP essential for survival of infected lymphoma cells.
Newspaper article from: Biotech Week June 23, 2004 700+ words
...HHV-8 vFLIP is essential for the survival of infected lymphoma cells. According to recent research from Cornell University...Medicine (KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med, 2004;199(7):993-1003). For additional...
Biomodulation of ONTAK Increases In Vitro Cytotoxicity in Leukemia and Lymphoma...
Press release article from: Business Wire May 23, 2000 700+ words
...regimen may increase the activity of ONTAK in patients whose lymphoma cells do not express the Interleukin-2 receptor (IL-2R...selectively lethal to IL-2R-expressing leukemia and lymphoma cells. This in vitro study suggests that biomodulatory strategies...
New drug Zevalin hones in on lymphoma cells to deliver a radioactive punch.
Newspaper article from: Akron Beacon Journal (Akron, Ohio) (via Knight-Ridder/Tribune News Service) July 8, 2002 700+ words
...Zevalin, however, is. It delivers radiation to specifically targeted cells, which in the case of non-Hodgkin's lymphoma, cells that are known as B-lymphocytes. Zevalin's precision relies on monoclonal antibodies, lab-concocted guides that...
New drug Zevalin hones in on lymphoma cells to deliver a radioactive...
Newspaper article from: Knight Ridder/Tribune News Service Wheeler, Tracy July 11, 2002 700+ words
...Zevalin, however, is. It delivers radiation to specifically targeted cells, which in the case of non-Hodgkin's lymphoma, cells that are known as B-lymphocytes. Zevalin's precision relies on monoclonal antibodies, lab-concocted guides that...
Experimental drug lets B cells live and lymphoma cells die.
Newspaper article from: NewsRx Health October 11, 2009 700+ words
An investigative drug deprived non-Hodgkin lymphoma cells of their ability to survive too long and multiply too fast, according to an early study published recently in the journal Experimental...
For more facts and information, see all results

Source: HighBeam Research, Section V: Biomedical Sciences.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA